Clinical Trial Update: The Impact of Rituximab in Patients With Primary Breast Diffuse Large B Cell Lymphoma (DLBCL)

View source ↗

Summary

A completed clinical trial evaluating the impact of Rituximab in patients with primary breast diffuse large B-cell lymphoma.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diffuse Large B-cell Lymphoma

Drugs mentioned

• Rituximab (rituximab)

Snippet

Sponsor: Chonbuk National University Hospital | Conditions: Lymphoma, Large B-Cell, Diffuse | Status: COMPLETED